The goal of this project is to understand the neurobiological underpinnings of the effects of ultrasound (US) on neural activity. US can modify action potential activity in neurons in vitro and in vivo without damaging neural tissue. This phenomenon can be applied in powerful new tools for basic and clinical neuroscience, with broad impact on public health issues related to mental and neurological disorders. To guide use of this new tool, our research will provide insight into the physical, biophysical and neural mechanisms underlying US neuromodulation. Our approach is unique in applying and integrating mechanistic studies of US neuromodulation at levels of complexity ranging from the single cell to the whole animal.
We aim to understand the relationship between US 1) the physical processes that transform acoustic energy to effects on biological systems and the resulting measurable physical variables (Aim 1), 2) the biophysical transduction processes together with the resulting measurable biophysical effects (Aim 2) 3) the subsequent neural integration processes that lead to the final output of the neural system or behavior (Aim 3). We will address these questions in experiments across three model systems (the in vivo mouse model, in vitro salamander and mouse retina, and single hippocampal pyramidal cells in acute and cultured brain slices), focusing on hypotheses guided by our results thus far. US neuromodulation is likely to have significant impact on public health. Brain stimulation therapies are used to treat Parkinson's disease, dystonia, and epilepsy and hold promise for many others. Compared to current brain stimulation techniques that rely on invasive implanted electrodes or have limited spatial resolution and depth penetration (e.g., transcranial magnetic stimulation), US offers an ideal combination of spatial resolution, depth penetration, and non-invasiveness. US neuromodulation can also be implemented in prosthetic devices; for example, to stimulate retinal circuitry to restore vision. In addition, US neuromodulation promises to become an enormously useful research tool in basic neuroscience, and it is therefore relevant to all mental and neurological disorders of public health concern. However, all these outcomes depend on the ability to apply US neuromodulation with well-controlled, predictable results. Achieving this goal requires a detailed mechanistic understanding of US neuromodulation that our multidisciplinary research project will provide.

Public Health Relevance

Ultrasonic neuromodulation is a promising new technology that has the potential to provide revolutionary new therapies for neurological disorders including Parkinson's disease, dystonia, epilepsy, Alzheimer's, anxiety, schizophrenia, and stroke. However, use of this technology is impeded by the limited understanding of the mechanism by which ultrasound stimulates brain activity. The proposed research will provide a mechanistic understanding necessary to catalyze development of ultrasonic neuromodulation therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS112152-01A1
Application #
9957860
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Kukke, Sahana Nalini
Project Start
2020-05-15
Project End
2025-02-28
Budget Start
2020-05-15
Budget End
2021-02-28
Support Year
1
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Stanford University
Department
Biophysics
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305